/Johnson%20%26%20Johnson%20location%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a diversified business model. With a market cap of $402.8 billion, Johnson & Johnson operates through pharmaceuticals, medical devices, and consumer products divisions.
The healthcare giant has notably lagged behind the broader market over the past year but outperformed it in 2025. JNJ stock has gained 13.9% on a YTD basis and 2.1% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 7.8% gains in 2025 and 16.6% returns over the past year.
